1. Home
  2. BBBY vs CTNM Comparison

BBBY vs CTNM Comparison

Compare BBBY & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bed Bath & Beyond Inc.

BBBY

Bed Bath & Beyond Inc.

HOLD

Current Price

$4.91

Market Cap

493.5M

Sector

N/A

ML Signal

HOLD

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

HOLD

Current Price

$14.37

Market Cap

550.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBBY
CTNM
Founded
1971
2009
Country
United States
United States
Employees
389
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
493.5M
550.7M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
BBBY
CTNM
Price
$4.91
$14.37
Analyst Decision
Hold
Buy
Analyst Count
3
4
Target Price
$8.00
$19.00
AVG Volume (30 Days)
2.3M
459.2K
Earning Date
04-27-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.46
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.35
N/A
Revenue Next Year
$7.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.26
$5.08
52 Week High
$12.65
$16.91

Technical Indicators

Market Signals
Indicator
BBBY
CTNM
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
BBBY
CTNM

About BBBY Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc is an e-commerce-focused retailer with an affinity model that owns or has ownership interests in various retail brands, offering products and services that enable its customers to enhance everyday life through quality, style, and value. The company currently owns Bed Bath & Beyond, Overstock, buybuy BABY, and other related brands and websites, as well as a blockchain asset portfolio. Its e-commerce platforms, www.bedbathandbeyond.com and www.overstock.com, are targeted at customers seeking various products such as furniture, bedding, area rugs, tabletop and cookware, decor, storage, jewelry, etc, at affordable prices. In addition to products, the company also offers add-on services across platforms, including warranties, shipping insurance, and installation services.

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.

Share on Social Networks: